
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis
Lei Tian, Mengdi Wang, Mengchao Liu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 4
Lei Tian, Mengdi Wang, Mengchao Liu, et al.
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 4
Showing 4 citing articles:
Real-world safety and effectiveness of Roxadustat in patients with anemia of chronic kidney disease: interim results from a post-marketing surveillance study in Japan
Kazuhiko Tsuruya, Haruko Sugamori, Yusuke Tanaka, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Kazuhiko Tsuruya, Haruko Sugamori, Yusuke Tanaka, et al.
Expert Opinion on Pharmacotherapy (2025)
Closed Access
Role of hypoxia-inducible factor 1 in type 1 diabetes
Raphael R. Fagundes, Arnaud Zaldumbide, Cormac T. Taylor
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 798-810
Closed Access | Times Cited: 3
Raphael R. Fagundes, Arnaud Zaldumbide, Cormac T. Taylor
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 798-810
Closed Access | Times Cited: 3
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors as a New Treatment Option for Anemia in Chronic Kidney Disease
Piotr Bartnicki
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 2
Piotr Bartnicki
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 2
What is the impact of anemia pharmacotherapy on chronic kidney disease progression?
Hanna T. Webb, Jay B. Wish
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1265-1269
Open Access
Hanna T. Webb, Jay B. Wish
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 10, pp. 1265-1269
Open Access